Sofinnova Investments’s Pharvaris PHVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.1M Buy
818,328
+73,159
+10% +$1.95M 0.88% 35
2025
Q4
$20.7M Buy
745,169
+5,293
+0.7% +$127K 0.89% 35
2025
Q3
$18.5M Buy
739,876
+154,344
+26% +$3.42M 1.01% 31
2025
Q2
$10.3M Sell
585,532
-7,871
-1% -$127K 0.63% 40
2025
Q1
$9.32M Buy
593,403
+32,680
+6% +$551K 0.61% 40
2024
Q4
$10.7M Sell
560,723
-39,579
-7% -$815K 0.78% 32
2024
Q3
$11.1M Sell
600,302
-1,232
-0.2% -$22.5K 0.88% 27
2024
Q2
$11.3M Buy
601,534
+16,862
+3% +$343K 0.59% 41
2024
Q1
$13.5M Buy
584,672
+74,231
+15% +$1.97M 0.75% 33
2023
Q4
$14.3M Buy
+510,441
New +$10.3M 0.8% 30

Other funds holding PHVS

Sofinnova Investments's PHVS Position: Q1 2026 in Review

Sofinnova Investments increased its Pharvaris (PHVS) stake by 9.8% in Q1 2026, buying an estimated $1.95M and bringing the position to 818,328 shares worth $23.1M. The position accounts for 0.88% of the portfolio, ranked #35.

Sofinnova Investments first reported a position in PHVS in Q4 2023 and has held it in 10 quarters since. 110 funds tracked by Wall St. Rank hold PHVS as of Q1 2026.

  • Sofinnova Investments held 818,328 shares of Pharvaris worth $23.1M as of Q1 2026.
  • Sofinnova Investments bought 73,159 Pharvaris shares in Q1 2026, an estimated $1.95M.
  • Pharvaris made up 0.88% of Sofinnova Investments's portfolio in Q1 2026, its #35 holding.
  • Sofinnova Investments first reported a position in Pharvaris in Q4 2023 and has held it in 10 quarters since.
  • 110 funds tracked by Wall St. Rank held Pharvaris as of Q1 2026.

Based on Sofinnova Investments's 13F filing for Q1 2026, filed 15 May 2026.